Phase 1 Motor Neurone Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must have already completed both the main treatment phase and any off-treatment phase of the parent study (called Study OWAA), including any required screening steps from a linked screening protocol.
Who may not be able to join:
- You have a history of significant back pain, back problems, or back injury (such as spinal surgery, a curved spine, or degenerative back disease) that could make a spinal fluid sample (lumbar puncture) difficult or risky.
- You are allergic to local anaesthetics such as lidocaine or similar medicines.
- You have a skin infection at the area of the back where the spinal fluid sample would be taken.
- Your platelet count (the blood cells that help clotting) is too low, you have a significant blood clotting problem, or you are currently experiencing significant active bleeding.
- You are currently taking blood-thinning medicines or medicines that affect blood clotting or platelet function — note that a low dose of aspirin (as defined by local medical guidelines) is allowed.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company
Phone: 1-317-615-4559
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants with One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.